X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (44) 44
index medicus (42) 42
female (39) 39
male (35) 35
middle aged (29) 29
aged (27) 27
adult (26) 26
hematology (19) 19
lymphomas (16) 16
transplantation (14) 14
analysis (13) 13
rituximab (13) 13
stem cells (13) 13
treatment outcome (13) 13
lymphoma (12) 12
adolescent (11) 11
patients (11) 11
survival (11) 11
young adult (11) 11
cancer (10) 10
immunology (10) 10
oncology (10) 10
prognosis (10) 10
follicular lymphoma (9) 9
retrospective studies (9) 9
risk factors (8) 8
chemotherapy (7) 7
follow-up studies (7) 7
aged, 80 and over (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
asthma (6) 6
health aspects (6) 6
hematology, oncology and palliative medicine (6) 6
hematopoietic stem cell transplantation (6) 6
hemic and lymphatic diseases (6) 6
lymphoma, large b-cell, diffuse - mortality (6) 6
non-hodgkins-lymphoma (6) 6
research (6) 6
stem cell transplantation (6) 6
studies (6) 6
autografts (5) 5
bone-marrow-transplantation (5) 5
child (5) 5
disease-free survival (5) 5
genetics & heredity (5) 5
hematopoietic stem cell transplantation - adverse effects (5) 5
immunohistochemistry (5) 5
inflammation (5) 5
limfomes (5) 5
phenotype (5) 5
risk (5) 5
survival analysis (5) 5
b-cell lymphoma (4) 4
chromosome deletion (4) 4
disease (4) 4
high-dose therapy (4) 4
immune system diseases (4) 4
internal medicine (4) 4
kaplan-meier estimate (4) 4
leukemia (4) 4
lymphoma, follicular - mortality (4) 4
lymphoma, large b-cell, diffuse - pathology (4) 4
lymphoma, large b-cell, diffuse - therapy (4) 4
medical research (4) 4
mortality (4) 4
multidisciplinary sciences (4) 4
mutations (4) 4
neoplasm staging (4) 4
pathology (4) 4
proportional hazards models (4) 4
quality of life (4) 4
registries (4) 4
sputum - cytology (4) 4
sputum eosinophils (4) 4
therapy (4) 4
thrombocytopenia (4) 4
transplantation conditioning - methods (4) 4
transplantation, homologous (4) 4
trial (4) 4
versus-host-disease (4) 4
abnormalities, multiple - genetics (3) 3
adrenal cortex hormones - therapeutic use (3) 3
algorithms (3) 3
allergy (3) 3
antineoplastic agents - therapeutic use (3) 3
asthma - drug therapy (3) 3
asthma - immunology (3) 3
asthma - physiopathology (3) 3
asthma control (3) 3
b cells (3) 3
biomarkers (3) 3
bone-marrow transplants (3) 3
cell biology (3) 3
cell survival (3) 3
chronic lymphocytic-leukemia (3) 3
clinical trials (3) 3
cohort studies (3) 3
comparative genomic hybridization (3) 3
cèl·lules mare (3) 3
disease progression (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1983, Pubblicazioni del "Centro di reicerche smiotiche" di Torino, Volume VII, 2, 198 p. --
Book
1974, Corpus della scultura altomedievale, Volume 6, 251 p., [63] leaves of plates (1 fold.)
Book
Lancet, The, ISSN 0140-6736, 2017, Volume 390, Issue 10094, pp. 555 - 566
Journal Article
Journal Article
Journal Article
2004, Supplementi di Lexis, ISBN 9025611885, Volume 14, xi, 312
Book
The Journal of Pathology, ISSN 0022-3417, 02/2015, Volume 235, Issue 3, pp. 445 - 455
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 09/2017, Volume 178, Issue 5, pp. 699 - 708
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 5519 - 5519
Abstract Introduction Follicular lymphoma (FL) is the most frequent indolent lymphoma. Autologous hematopoietic stem cell transplantation (ASCT) allows durable... 
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 11/2019, Volume 9, Issue 1, pp. 1 - 9
Very few data exist on when a particular thrombopoietin-receptor agonist (TPO-RA) is favored in clinical practice for the treatment of patients with immune... 
EFFICACY | ITP | ROMIPLOSTIM | PURPURA | MULTIDISCIPLINARY SCIENCES | DOUBLE-BLIND | ELTROMBOPAG | CANCER | REMISSION | Thrombocytopenia | Splenectomy | Agonists | Patients | Risk factors | Immunosuppressive agents | Thrombopoietin
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2018, Volume 13, Issue 6, p. e0198789
Journal Article
British Journal of Haematology, ISSN 0007-1048, 05/2019, Volume 185, Issue 3, pp. 480 - 491
Summary The use of immunochemotherapy has improved the outcome of follicular lymphoma (FL). Recently, complete response at 30 months (CR30) has been suggested... 
follicular lymphoma | complete response | survival | 1ST-LINE TREATMENT | SURROGATE END-POINT | FREE SURVIVAL | R-CHOP | PLUS RITUXIMAB | INITIAL TREATMENT | PROGNOSTIC VALUE | TRIAL | THERAPY | CVP | HEMATOLOGY | Lymphomas | Life expectancy | Health aspects | Analysis | Training | Life span | Sex | Rituximab | Multivariate analysis | Lymphoma | Patients | Survival
Journal Article